预防性高血容量增强血压方案与延迟夹闭的动脉瘤性蛛网膜下腔出血患者迟发性脑缺血的相关性
该研究纳入2013—2019年泰国一所大学医院中在破裂后4—7天行夹闭术的动脉瘤性蛛网膜下腔出血患者,比较达成与未达成高血容量增强血压(HV-ABP)方案者的迟发性脑缺血(DCI)情况,结果显示达成方案与DCI发生率降低相关。
要点
- HV-ABP方案为每日液体摄入3—5 L并维持收缩压140—180 mmHg共72小时(术后)。
- 达成方案者DCI发生率为8.3%,未达成者为22.5%。
- 全样本校正OR为0.201(95%CI 0.066—0.613),倾向评分匹配子样本为0.228(95%CI 0.065—0.794)。
核心结论
- 达成HV-ABP方案推荐目标与延迟夹闭的动脉瘤性蛛网膜下腔出血患者DCI发生率降低相关。
研究设计与样本
- 研究纳入2013—2019年泰国一所大学医院中于破裂后4—7天行夹闭术的动脉瘤性蛛网膜下腔出血患者,共177例,其中97例(54.8%)达成HV-ABP方案、80例(45.2%)未达成;采用逻辑回归分析全组及倾向评分匹配子样本(122例,一对一匹配)的干预—结局关联。
主要发现
- 达成HV-ABP方案者DCI发生率为8.3%,未达成者为22.5%。
- 全样本校正OR为0.201(95%CI 0.066—0.613),倾向评分匹配子样本为0.228(95%CI 0.065—0.794)。
- 次要结局在各组间均无统计学显著差异。
关键数值与推荐
- HV-ABP方案:每日液体摄入3—5 L,维持收缩压140—180 mmHg,术后持续72小时。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prior trials investigating triple-H therapy for preventing delayed cerebral ischemia (DCI) enrolled patients with aneurysmal subarachnoid hemorrhage (aSAH) who underwent early aneurysm therapy within 3 days. However, surgical clipping might be performed during 4-7 days that high incidence cerebral vasospasm is likely. We examined effects of hypervolemia-augmented blood pressure (HV-ABP) protocol on DCI prevention when clipping was delayed. METHODS: The study enrolled aSAH patients hospitalized during 2013-2019 who underwent clipping 4-7 days after rupture in a university hospital in Thailand. DCI and secondary outcomes were compared among patients who achieved the HV-ABP protocol (3-5 L/day fluid intake and 140-180 mmHg systolic blood pressure maintained for 72 hours postoperatively) and those who did not. The intervention-outcome associations were estimated using logistic regression for the whole group and a patient subgroup with similar propensity scores (PS) for protocol achievement. RESULTS: One hundred seventy-seven aSAH patients were clipped 4-7 days after rupture; 97 patients (54.8%) achieved the HV-ABP protocol, while 80 patients (45.2%) did not. One hundred twenty-two patients with one-to-one PS matching reduced the originally unequal patient characteristics. The observed DCI was lower in patients with protocol-achieved (8.3%) than in their nonachieved counterparts (22.5%). This resulted in an association with the HV-ABP intervention with adjusted odds ratios of 0.201 (95% confidence interval, 0.066-0.613) in the whole sample and 0.228 (0.065-0.794) in the PS-matched subsample. No statistically significant differences in the secondary outcomes were found. CONCLUSIONS: Achieving the targets recommended in the HV-ABP protocol was associated with reducing the DCI incidence in patients with aSAH who underwent delayed clipping.
引用
- Greetawee J, Duangthongphon P, Limwattananon P, et al. An Association Between Prophylactic Hypervolemia-Augmented Blood Pressure and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage Who Underwent Delayed Clipping. World Neurosurg. 2024. PMID: 39013498. doi:10.1016/j.wneu.2024.07.083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。